...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Australian Economic Review >Policy Forum: Privatising ScienceDo Patents and Intellectual Property Protection Hinder Biomedical Research? A Practical Perspective
【24h】

Policy Forum: Privatising ScienceDo Patents and Intellectual Property Protection Hinder Biomedical Research? A Practical Perspective

机译：政策论坛：科学私有化专利和知识产权保护会阻碍生物医学研究吗？实用的观点

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The true value of society's investment in biomedical research comes from translation into advances benefitting health and wellbeing. In the case of therapeutic, diagnostic and preventative interventions, such translation usually depends on the granting of a temporary monopoly, through patent rights, to secure a period of commercial exclusivity justifying the risk of investment. Consequently, debate arises about freedom of research activities and their purported inhibition due to intellectual property(IP) rights protection. This article argues there is a lack of evidence that IP protection measures have a significant negative impact on academic biomedical research. This perspective is developed from the experience over the last ten years of a majorAustralian medical research institute, as well as the practical experience of the author, who has worked actively in senior international positions at the academic and commercial biomedical research interface since 1978.
机译：社会对生物医学研究的投资的真正价值在于将其转化为有益于健康和福祉的进步。就治疗，诊断和预防措施而言，这种翻译通常取决于通过专利权授予临时垄断权，以确保一定时期的商业独占性，从而证明投资风险是合理的。因此，关于研究活动的自由及其声称由于知识产权（IP）保护而受到的限制引起了争论。本文认为，缺乏证据表明知识产权保护措施会对学术生物医学研究产生重大负面影响。这种观点是根据澳大利亚一家大型医学研究所过去十年的经验以及作者的实践经验发展而来的。作者自1978年以来一直在学术和商业生物医学研究界的国际高级职位上积极工作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号